HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Imidazenil, a partial positive allosteric modulator of GABAA receptors, exhibits low tolerance and dependence liabilities in the rat.

Abstract
Long-term treatment of rats with full (triazolam) or selective (diazepam) allosteric modulators of gamma-aminobutyric acid type A (GABAA) receptors rapidly induced tolerance to the protective effect of these drugs against bicuculline-induced convulsion. In contrast, long-term administration of partial allosteric modulators (imidazenil and bretazenil) of GABAA receptors, in doses equipotent to those of diazepam and triazolam that induce anticonvulsant tolerance, failed to elicit such a tolerance. Furthermore, no cross-tolerance was observed between diazepam and imidazenil. Discontinuation of long-term treatment with diazepam or triazolam, but not of long-term treatment with imidazenil or bretazenil, sensitized rats to behavioral inhibition by punishment (electric shock) in a manner that was potentiated by flumazenil. Administration of a single oral dose of [14C]diazepam or [3H] imidazenil to rats treated repeatedly with the corresponding unlabeled drug or vehicle revealed that the brain concentrations of drugs and their metabolites were similar in both groups of animals. This suggests that tolerance to the full or selective allosteric modulators of GABAA receptors may be associated with changes in the efficacy of the allosteric modulation rather than with changes in drug metabolism. Imidazenil has a longer half-life than an equipotent dose of diazepam and protects rats against bicuculline-induced convulsions for a significantly longer time than diazepam or bretazenil.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsJ Auta, P Giusti, A Guidotti, E Costa
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 270 Issue 3 Pg. 1262-9 (Sep 1994) ISSN: 0022-3565 [Print] United States
PMID7932179 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anticonvulsants
  • Benzodiazepinones
  • GABA Modulators
  • Imidazoles
  • Benzodiazepines
  • Triazolam
  • imidazenil
  • bretazenil
  • Diazepam
Topics
  • Allosteric Regulation
  • Animals
  • Anticonvulsants (pharmacology)
  • Benzodiazepines (metabolism, pharmacology)
  • Benzodiazepinones (pharmacology)
  • Brain (metabolism)
  • Diazepam (metabolism, pharmacology)
  • Drug Interactions
  • Drug Tolerance
  • GABA Modulators (pharmacology)
  • Imidazoles (metabolism, pharmacology)
  • Male
  • Rats
  • Rats, Sprague-Dawley
  • Substance-Related Disorders
  • Triazolam (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: